April 8, 2026 Scalable Approaches to Patient-Centered Benefit–Risk: Defining Patient-Focused Drug Development in Precision Medicine As precision medicine advances, approaches to benefit–risk must evolve beyond traditional models designed...
March 19, 2026 Meeting Patients Where They Are: Validating Remote Digital Tools for Multi-Indication NMD Research The C-Path team is pleased to invite you to an upcoming webinar to discuss the scientific...
March 5, 2026-March 6, 2026 27th NIH Tissue Chip Consortium Meeting + CIVM Qualification Framework Public Workshop Please join us at the 27th National Institute of Health (NIG) Tissue Chip Consortium...
February 25, 2026 View Now: Transforming Drug Development for Precision Medicines — A Practical Path from Evidence Generation to Reimbursement The C-Path team is pleased to invite you to an upcoming webinar that brings together drug development...
January 27, 2026 C-Path’s Translational Therapeutics Accelerator Award Funding Opportunities 2026 C-Path) and the PKD Foundation hosted a webinar to discuss C-Path's Transplant Therapeutics Accelerator (TRxA)...
December 11, 2025 Recording Available: From Vision to Reality — 6 Years of RDCA-DAP, Driving Drug Development Solutions and Innovations in Data Sharing This session will demonstrate how data sharing can move mountains for rare disease research — with real-world examples...
June 2, 2025 Lysosomal Storage Disease Data Sharing Workshop, Webinar Series Session #4: Case Studies #3 – Data Sharing Collaboratives Critical Path Institute's Critical Path for Lysosomal Diseases (CPLD) Consortium presents, Lysosomal Storage Disease...
May 22, 2025 RDCA-DAP and NORD’s IAMRARE Platform to Platform Federation: Lessons Learned Patient data is a key asset in understanding the progression of rare diseases...
April 28, 2025 Lysosomal Storage Disease Data Sharing Webinar Series – Session #3: Retroactive Data Sharing The recent webinar from C-Path's Critical Path for Lysosomal Diseases (CPLD) team focused on the critical issue of...
April 17, 2025 RDCA-DAP Webinar: ACE Inhibitors as a Cardioprotective Treatment in Dystrophinopathies ACE inhibitors were the first pharmacological class shown to benefit heart failure treatment...
